Literature DB >> 4398937

Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway.

S F Travis, A D Morrison, R S Clements, A I Winegrad, F A Oski.   

Abstract

Human erythrocytes incubated in medium containing 50 mM glucose have increased intracellular sorbitol and fructose concentrations as compared with samples incubated with 5 mM glucose. Increased medium glucose concentration did not significantly alter total glucose consumption or lactate production. However, the intracellular lactate:pyruvate ratio rose, the concentrations of fructose diphosphate, and triose phosphates increased, and the 2,3-diphosphoglycerate concentration fell. [(14)C]O(2) production from glucose-1-(14)C also increased with increased medium glucose concentration. These changes are believed to reflect changes in the redox states of the diphosphopyridine nucleotide/reduced form of diphosphopyridine nucleotide (NAD/NADH) and nicotinamide-adenine dinucleotide phosphate/reduced form of nicotinamide-adenine dinucleotide phosphate (NADP/NADPH) couples resulting from increased activity of the polyol pathway. Addition of pyruvate to the incubation media prevented these changes. These studies illustrate that an increase in the red cell's normal substrate, glucose, can produce changes in red cell metabolism.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4398937      PMCID: PMC292144          DOI: 10.1172/JCI106704

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Studies on erythrocyte glycolysis. II. Free energy changes and rate limitings steps in erythrocyte glycolysis.

Authors:  S Minakami; H Yoshikawa
Journal:  J Biochem       Date:  1966-02       Impact factor: 3.387

2.  The distribution of polyol: NADP oxidoreductase in mammalian tissues.

Authors:  R S Clements; J P Weaver; A I Winegrad
Journal:  Biochem Biophys Res Commun       Date:  1969-10-08       Impact factor: 3.575

3.  Non-glycolytic sugar metabolism in human erythrocytes. I. Xylitol metabolism.

Authors:  T Asakura; K Adachi; S Minagami; H Yoshikawa
Journal:  J Biochem       Date:  1967-08       Impact factor: 3.387

4.  Pentose phosphate pathway metabolism by normal and glucose-6-phosphate dehydrogenase-deficient human red cell haemolysates.

Authors:  J A Sturman
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

5.  The enzymatic assay of pyruvic and lactic acids. A definitive procedure.

Authors:  A G Hadjivassiliou; S V Rieder
Journal:  Clin Chim Acta       Date:  1968-03       Impact factor: 3.786

6.  Control of glycolysis in the human red blood cell.

Authors:  I A Rose; J V Warms
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

7.  Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia.

Authors:  M A Stewart; W R Sherman; M M Kurien; G I Moonsammy; M Wisgerhof
Journal:  J Neurochem       Date:  1967-11       Impact factor: 5.372

8.  Purification and properties of brain aldose reductase and L-hexonate dehydrogenase.

Authors:  G I Moonsammy; M A Stewart
Journal:  J Neurochem       Date:  1967-12       Impact factor: 5.372

9.  Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.

Authors:  K H Gabbay; L O Merola; R A Field
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

10.  Hemolytic anemia with impaired hexokinase activity.

Authors:  A S Keitt
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

View more
  28 in total

1.  Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.

Authors:  D Bareford; P E Jennings; P C Stone; S Baar; A H Barnett; J Stuart
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

2.  Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.

Authors:  J R Williamson; E Ostrow; D Eades; K Chang; W Allison; C Kilo; W R Sherman
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Regulation and control of glucose overutilization in erythrocytes by vanadate.

Authors:  N Z Baquer; A K Saxena; P Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  2,3-Diphosphoglycerate fluctuations in erythrocytes reflecting pronounced blood glucose variation. In-vivo and in-vitro studies in normal, diabetic and hypoglycaemic subjects.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1973-12       Impact factor: 10.122

5.  The effect of scald injury upon the distribution of glucose between red cells and plasma and upon the turnover of glucose in red cells in the rat.

Authors:  D F Heath
Journal:  Br J Exp Pathol       Date:  1973-08

6.  The reduction of glyceraldehyde by human erythrocytes. L-hexonate dehydrogenase activity.

Authors:  E Beutler; E Guinto
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

7.  Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells.

Authors:  T P Thomas; F Porcellati; K Kato; M J Stevens; W R Sherman; D A Greene
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Human erythrocyte sorbitol metabolism and the role of sorbitol dehydrogenase.

Authors:  Y Nagasaka; S Fujii; T Kaneko
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

9.  Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation.

Authors:  Yasuo Ido; Jens R Nyengaard; Kathy Chang; Ronald G Tilton; Charles Kilo; Banavara L Mylari; Peter J Oates; Joseph R Williamson
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

10.  A fluorimetric method for red blood cell sorbitol dehydrogenase activity.

Authors:  G Vaca; P Zúñiga; C Medina; R Alonso; G González-Quiroga; R I Ortíz-De-Luna; J M Cantú
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.